TOVX logo

Theriva Biologics (TOVX) Current Liabilities

Annual Current Liabilities

$6.74 M
-$322.00 K-4.56%

31 December 2023

TOVX Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Liabilities

$7.32 M
+$475.00 K+6.94%

01 September 2024

TOVX Quarterly Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TOVX Current Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-4.6%-16.2%
3 y3 years+127.2%+106.0%
5 y5 years+27.7%+38.8%

TOVX Current Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-4.6%+127.2%-44.8%+106.0%
5 y5 years-4.6%+127.2%-44.8%+249.1%
alltimeall time-65.9%+3269.0%-71.3%

Theriva Biologics Current Liabilities History

DateAnnualQuarterly
Sept 2024
-
$7.32 M(+6.9%)
June 2024
-
$6.85 M(+14.0%)
Mar 2024
-
$6.01 M(-10.8%)
Dec 2023
$6.74 M(-4.6%)
$6.74 M(-22.9%)
Sept 2023
-
$8.74 M(-4.3%)
June 2023
-
$9.13 M(+6.0%)
Mar 2023
-
$8.62 M(+22.1%)
Dec 2022
$7.06 M(+98.6%)
$7.06 M(-46.5%)
Sept 2022
-
$13.19 M(-0.5%)
June 2022
-
$13.26 M(+20.8%)
Mar 2022
-
$10.98 M(+208.8%)
Dec 2021
$3.55 M(+19.8%)
-
Dec 2021
-
$3.55 M(+12.5%)
Sept 2021
-
$3.16 M(+50.6%)
June 2021
-
$2.10 M(-1.1%)
Mar 2021
-
$2.12 M(-28.5%)
Dec 2020
$2.97 M(-43.8%)
$2.97 M(-1.5%)
Sept 2020
-
$3.01 M(-12.2%)
June 2020
-
$3.43 M(+19.2%)
Mar 2020
-
$2.88 M(-45.5%)
Dec 2019
$5.28 M(+55.9%)
$5.28 M(-6.4%)
Sept 2019
-
$5.63 M(+47.8%)
June 2019
-
$3.81 M(+28.7%)
Mar 2019
-
$2.96 M(-12.5%)
Dec 2018
$3.38 M(-65.4%)
$3.38 M(-13.5%)
Sept 2018
-
$3.91 M(-9.4%)
June 2018
-
$4.32 M(-15.1%)
Mar 2018
-
$5.09 M(-48.1%)
Dec 2017
$9.79 M(-50.4%)
$9.79 M(-44.1%)
Sept 2017
-
$17.52 M(+42.1%)
June 2017
-
$12.33 M(-25.2%)
Mar 2017
-
$16.49 M(-16.5%)
Dec 2016
$19.76 M(+26.9%)
$19.76 M(+41.0%)
Sept 2016
-
$14.01 M(-7.7%)
June 2016
-
$15.17 M(-13.4%)
Mar 2016
-
$17.53 M(+12.5%)
Dec 2015
$15.57 M(+62.4%)
$15.57 M(-10.0%)
Sept 2015
-
$17.30 M(-32.1%)
June 2015
-
$25.50 M(+66.2%)
Mar 2015
-
$15.34 M(+60.0%)
Dec 2014
$9.59 M(+833.6%)
$9.59 M(+874.4%)
Sept 2014
-
$984.00 K(-20.1%)
June 2014
-
$1.23 M(+59.4%)
Mar 2014
-
$773.00 K(-24.7%)
Dec 2013
$1.03 M(+160.0%)
$1.03 M(+75.9%)
Sept 2013
-
$584.00 K(+155.0%)
June 2013
-
$229.00 K(+16.8%)
Mar 2013
-
$196.00 K(-50.4%)
Dec 2012
$395.00 K(-5.3%)
$395.00 K(-5.3%)
Sept 2012
-
$417.00 K(+5.6%)
June 2012
-
$395.00 K(-10.8%)
Mar 2012
-
$443.00 K(+6.2%)
Dec 2011
$417.00 K(-16.6%)
$417.00 K(+78.2%)
Sept 2011
-
$234.00 K(-41.2%)
June 2011
-
$397.90 K(-66.4%)
Mar 2011
-
$1.18 M(+136.6%)
DateAnnualQuarterly
Dec 2010
$500.00 K(+17.5%)
$500.00 K(+50.7%)
Sept 2010
-
$331.80 K(-40.7%)
June 2010
-
$559.70 K(+55.6%)
Mar 2010
-
$359.60 K(-15.5%)
Dec 2009
$425.60 K(-31.4%)
$425.60 K(+55.4%)
Sept 2009
-
$273.90 K(-39.4%)
June 2009
-
$452.10 K(-30.1%)
Mar 2009
-
$647.10 K(+4.3%)
Dec 2008
$620.70 K(-63.2%)
$620.70 K(-8.3%)
Sept 2008
-
$677.00 K(-17.1%)
June 2008
-
$816.20 K(-38.0%)
Mar 2008
-
$1.32 M(-21.9%)
Dec 2007
$1.69 M(+131.5%)
$1.69 M(+45.5%)
Sept 2007
-
$1.16 M(-9.5%)
June 2007
-
$1.28 M(+72.8%)
Mar 2007
-
$741.90 K(+1.8%)
Dec 2006
$729.00 K(-66.0%)
$729.00 K(>+9900.0%)
Sept 2006
-
$3000.00(>+9900.0%)
June 2006
-
$0.00(-100.0%)
Mar 2006
-
$9400.00(-99.8%)
Dec 2005
$2.14 M(-57.3%)
-
Mar 2003
-
$5.43 M(+8.2%)
Dec 2002
$5.02 M(-9.2%)
$5.02 M(+44.2%)
Sept 2002
-
$3.48 M(+21.1%)
June 2002
-
$2.88 M(+16.8%)
Mar 2002
-
$2.46 M(-55.5%)
Dec 2001
$5.53 M(+276.3%)
$5.53 M(+73.4%)
Sept 2001
-
$3.19 M(+74.3%)
June 2001
-
$1.83 M(+70.1%)
Mar 2001
-
$1.08 M(-26.8%)
Dec 2000
$1.47 M(+23.1%)
$1.47 M(+78.3%)
Sept 2000
-
$824.90 K(-3.8%)
June 2000
-
$857.30 K(-6.7%)
Mar 2000
-
$918.90 K(-23.1%)
Dec 1999
$1.19 M(-0.4%)
$1.19 M(-25.3%)
Sept 1999
-
$1.60 M(+60.0%)
June 1999
-
$1.00 M(-9.1%)
Mar 1999
-
$1.10 M(-8.3%)
Dec 1998
$1.20 M(-14.3%)
$1.20 M(+20.0%)
Sept 1998
-
$1.00 M(-16.7%)
June 1998
-
$1.20 M(-61.3%)
Mar 1998
-
$3.10 M(+121.4%)
Dec 1997
$1.40 M(+27.3%)
$1.40 M(+27.3%)
Sept 1997
-
$1.10 M(+22.2%)
June 1997
-
$900.00 K(-40.0%)
Mar 1997
-
$1.50 M(+36.4%)
Dec 1996
$1.10 M(+175.0%)
$1.10 M(+57.1%)
Sept 1996
-
$700.00 K(-12.5%)
June 1996
-
$800.00 K(+100.0%)
Mar 1996
-
$400.00 K(0.0%)
Dec 1995
$400.00 K(-55.6%)
$400.00 K(0.0%)
Sept 1995
-
$400.00 K(-55.6%)
Dec 1994
$900.00 K(+350.0%)
$900.00 K(+350.0%)
Mar 1994
-
$200.00 K(0.0%)
Dec 1993
$200.00 K
$200.00 K(0.0%)
June 1993
-
$200.00 K(-77.8%)
Mar 1993
-
$900.00 K

FAQ

  • What is Theriva Biologics annual total current liabilities?
  • What is the all time high annual current liabilities for Theriva Biologics?
  • What is Theriva Biologics annual current liabilities year-on-year change?
  • What is Theriva Biologics quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Theriva Biologics?
  • What is Theriva Biologics quarterly current liabilities year-on-year change?

What is Theriva Biologics annual total current liabilities?

The current annual current liabilities of TOVX is $6.74 M

What is the all time high annual current liabilities for Theriva Biologics?

Theriva Biologics all-time high annual total current liabilities is $19.76 M

What is Theriva Biologics annual current liabilities year-on-year change?

Over the past year, TOVX annual total current liabilities has changed by -$322.00 K (-4.56%)

What is Theriva Biologics quarterly total current liabilities?

The current quarterly current liabilities of TOVX is $7.32 M

What is the all time high quarterly current liabilities for Theriva Biologics?

Theriva Biologics all-time high quarterly total current liabilities is $25.50 M

What is Theriva Biologics quarterly current liabilities year-on-year change?

Over the past year, TOVX quarterly total current liabilities has changed by -$1.42 M (-16.24%)